Authors' Affiliations: Department of Biomedicine, University of Basel; and Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Cancer Res. 2014 Mar 1;74(5):1566-75. doi: 10.1158/0008-5472.CAN-13-1641. Epub 2014 Jan 10.
An epithelial-mesenchymal transition (EMT) underlies malignant tumor progression and metastatic spread by enabling cancer cells to depart from the primary tumor, invade surrounding tissue, and disseminate to distant organs. EMT also enriches for cancer stem cells (CSC) and increases the capacity of cancer cells to initiate and propagate tumors upon transplantation into immune-deficient mice, a major hallmark of CSCs. However, the molecular mechanisms promoting the tumorigenicity of cancer cells undergoing an EMT and of CSCs have remained widely elusive. We here report that EMT confers efficient tumorigenicity to murine breast cancer cells by the upregulated expression of the proangiogenic factor VEGF-A and by increased tumor angiogenesis. On the basis of these data, we propose a novel interpretation of the features of CSCs with EMT-induced, VEGF-A-mediated angiogenesis as the connecting mechanism between cancer cell stemness and tumor initiation.
上皮-间充质转化 (EMT) 通过使癌细胞离开原发性肿瘤、侵袭周围组织并扩散到远处器官,为恶性肿瘤的进展和转移扩散提供了基础。EMT 还富集了癌症干细胞 (CSC),并增加了癌细胞在移植到免疫缺陷小鼠中引发和增殖肿瘤的能力,这是 CSC 的主要标志之一。然而,促进经历 EMT 的癌细胞和 CSC 的致瘤性的分子机制仍然广泛难以捉摸。我们在这里报告,EMT 通过上调促血管生成因子 VEGF-A 的表达和增加肿瘤血管生成,赋予了小鼠乳腺癌细胞高效的致瘤性。基于这些数据,我们提出了一种新的解释,认为 EMT 诱导的、VEGF-A 介导的血管生成的 CSC 特征是癌细胞干性和肿瘤起始之间的连接机制。